# OnCo record paper-katherine-nejm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-katherine-nejm-2019" ;
schema:name "KATHERINE: switching to T-DM1 when HER2-positive breast cancer survives pre-surgery treatment"@en ;
schema:description "Women whose HER2-positive breast cancer was still present at surgery after chemotherapy and trastuzumab had half the risk of relapse if their post-surgery treatment was switched to the antibody-drug conjugate T-DM1 instead of continuing trastuzumab."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2019"^^xsd:gYear ;
schema:author "von Minckwitz G, Huang CS, Mano MS, et al." ;
onco:related ;
onco:cancers ;
onco:technologies ;
onco:targets ;
onco:drugs , ;
onco:companies ;
onco:terms , , ;
onco:trials , ;
onco:people , , , ;
onco:bottlenecks , ;
onco:journals .